Welcome to the Schreiner MediPharm Press Room

Visit Schreiner MediPharm’s Press Room and read about our innovative solutions for the pharmaceutical and medical device industry. Please let us know if you have any questions or require information about additional topics. 

Schreiner MediPharm International

Schreiner MediPharm in cooperation with Swiss-based Ypsomed developed an NFC-Label that is applied to the YpsoMate® autoinjector and transmits stored information about the medication to its electronic add-on – the novel SmartPilot™. Thus, the data recorded about the use of the autoinjector logged by the SmartPilot™ are ideally complemented. The resulting connected device enhances the safety of patients and assists them in the self-administration of medicines in order to better comply with prescribed therapies.     Read more

Schreiner MediPharm International

Schreiner MediPharm’s trade fair presentation at Pharmapack 2019 in Paris will be fully focused on smart packaging solutions. On February 6 and 7, in Hall 7.2, Booth B32, the specialist for innovative labels and marking solutions with value-added benefits will showcase its latest product development in the field of digital therapy monitoring: The new “Smart Vial Kit” enables electronic tracking and monitoring of medication dispensing and intake.     Read more

Schreiner MediPharm International

For UV and light protection of particularly sensitive medicines such as biopharmaceuticals, biosimilars, blood products, vaccines and vitamin preparations, Schreiner MediPharm developed three novel labels at various safety levels. They reliably protect liquid substances in transparent glass containers against the damaging effects of exposure to UV irradiation and light. At the same time, they make it possible to check the liquid in the container for its impeccable original condition.     Read more

Schreiner MediPharm International

A novel dosing syringe label by Schreiner MediPharm supports reliable and exact dosing of a medicine for children as part of a clinical trial. The specialty label was developed for the syringe system made by Raumedic. It serves as a visual barrier, protecting the adjustment button and prevents healthcare staff from accidently activating the mechanism too early. Potential dosage errors of the medicine and false trial outcomes can thus be avoided.     Read more

Schreiner MediPharm International

The EU Falsified Medicines Directive (FMD) requires pharmaceutical manufacturers to serialize their products and to provide secondary product packaging with an anti-tampering device. Primary containers or devices such as pens and autoinjectors for self-medication, however, are not included in these requirements yet. Schreiner MediPharm has developed an NFC-Label for autoinjectors that enables digital tamper evidence on primary packaging and makes it possible for pharmaceutical manufacturers to close this risk gap.     Read more

Schreiner MediPharm International

The Europe-wide Falsified Medicines Directive 2011/62/EU coming into force in February 2019 requires all pharmaceutical manufacturers to mark their prescription medicine packaging with a serial number and an additional tamper protection device. Schreiner MediPharm’s multifunctional Covert-Hologram Seal with an irreversible, holographic effect offers reliable first-opening indication and tamper evidence, plus counterfeiting protection, and complies with the requirements of the EU Directive.     Read more

Schreiner MediPharm International

Schreiner MediPharm in collaboration with tube manufacturer Neopac and machine producer Harro Höfliger developed an innovative label for a pharmaceutical tube. The special marking label encloses the tube like a pocket, offers ample space for information and can be automatically dispensed on packaging lines.     Read more

Schreiner MediPharm International

For a multinational pharmaceutical corporation, Schreiner MediPharm developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.     Read more

Schreiner MediPharm International

International pharmaceutical corporation Pfizer opted for Schreiner MediPharm’s Needle-Trap needle protection label to equip the syringes for its epoetin biosimilar. This makes it the first medication for the treatment of anemia to be launched on the market with Needle-Trap–initially in Germany and Austria, to be followed by a successive rollout on the European market.     Read more

Schreiner MediPharm International

The countdown is on: On February 9, 2019, EU Directive 2011/62/EU will come into effect. It aims to stop illegal trade in falsified medicines. From then onwards, pharmaceutical manufacturers have to provide secondary packaging of all medicines placed on the market with an individual serial number as well as an anti-tampering device to ensure the integrity of the medicinal packaging: a challenge that should not be underestimated and demands customized and efficient solutions. At Pharmapack in Paris on February 7 and 8, 2018, Schreiner MediPharm will present its extensive portfolio of innovative analog and digital security solutions for reliable counterfeiting and tampering protection in Hall 7.1, Booth J48. The highlight of the product lineup will be the BitSecure copy detection pattern which enables easy, digital authentication of pharmaceutical packaging using a smartphone app.     Read more